[Protective action of contrical in rats with experimental nephritis].
It has been shown in rats with experimental uranyl-glycerin nephritis that contrykal relieves the severity of the disease acute phase. As compared with untreated animals, this fact is confirmed by the reduced albuminuria and blood urea, as well as by the absence of decreased filtration characteristic of glomerulonephritis. It has been also discovered that contrykal normalizes the urinary sediment, the blood urea and creatinine levels, and eliminates albuminuria and natriuresis.
D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004231:Diuresis; D005990:Glycerol / Q000008:administration & dosage; D009318:Natriuresis; D009393:Nephritis / Q000139:chemically induced / Q000188:drug therapy*; D011188:Potassium / Q000652:urine; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy; D051381:Rats; D014502:Uranyl Nitrate / Q000008:administration & dosage
D011480:Protease Inhibitors; D014502:Uranyl Nitrate; D007611:Aprotinin; D003404:Creatinine; D005990:Glycerol; D011188:Potassium
Zashchitnoe deĭstvie kontrikala pri éksperimental'nom nefrite u krys.